Introduction {#sec1}
============

Carbazoles are important heterocyclic molecules of high natural abundance^[@ref1]^ with a broad range of pharmaceutical^[@ref2]^ and material applications.^[@ref3]^ In particular, the iodocarbazoles due to the possible functionalization at iodide into highly conjugated polymeric aromatic systems having a great practical application^[@ref4]^ in organic light emitting diodes,^[@ref5]^ solar cells,^[@ref6]^ organic thin film transistors,^[@ref7]^ organic photovoltaic cells,^[@ref8]^ and so forth. Owing to these reasons, great interest has been devoted toward the development of efficient synthetic methods for the synthesis of carbazoles and their derivatives.^[@ref9]^ Few elegant approaches were reported for the synthesis of iodocarbazoles,^[@ref10]^ the benzannulation at C-2 and C-3 positions of indole from an alkyne-tethered indole substrate is one of the attractive and challenging methods due to the selective formation and step economy.^[@ref11]^ Few research groups have studied the reactivity of alkynes tethered to indoles at the C-3 position;^[@ref12]^ nevertheless, the synthesis of iodocarbazoles from these substrates is not well studied. Alcaide and co-workers have reported the synthesis of 3-iodocarbazoles from (3-iodoindol-2-yl)butynols via a gold-catalyzed intramolecular iodine transfer reaction ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, eq i).^[@ref13]^ Later, Wang et al. reported the synthesis of 3-iodocarbazoles using ICl/K~2~CO~3~ ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}, eq ii) from α-hydroxy substrates (homopropargyl alcohol tethered with indole).^[@ref14]^ Recently, Sanz and co-workers reported an elegant approach for the synthesis of 1-(indol-3-yl)carbazoles via Au(III)-catalyzed cycloisomerization of bisindolylmethane-tethered homopropargyl alcohols by demonstrating indole migration.^[@ref15]^ On the other hand, a remarkable change toward green chemical processes has been emerging since the last two decades.^[@ref16]^ In recent years, π-Lewis acid-mediated cycloisomerization reactions have become an attractive synthesis because of their atom and step economy.^[@ref17]^ Therefore, a variety of metal salts (Cu, Ag, Au, Pt, Hg, In, and Ca) have been employed to catalyze such transformations. Though most of these reactions are atom- and step-economic, expensive transition-metal catalysts, halogenated solvents, inert atmosphere, and high temperatures are some of the limiting factors of these reactions. Hence, we propose here to develop a synthetic procedure of these substrates under open-flask conditions with molecular iodine as the reagent at room temperature together with density functional theory (DFT) calculations to shed light on the mechanism.

![Strategies for 3-iodocarbazoles from (a) indole-tethered homopropargyl alcohols (previous) and (b) indolylmethane-tethered propargyl alcohols (current work).](ao-2018-02393c_0001){#fig1}

Results and Discussion {#sec2}
======================

We commenced our investigation by treating 1,1-bis(1*H*-indol-3-yl)-2,4-diphenylbut-3-yn-2-ol **1a**([@ref15]) with 2 equiv of molecular iodine in ethyl acetate at room temperature and noticed that **1a** was completely consumed in 1 h. The spectral data confirmed that the isolated product is a 3-iodocarbazole \[1-(1*H*-indol-3-yl)-3-iodo-2,4-diphenyl-9*H*-carbazole\] (**2a**) (entry 1, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). To increase the reaction yield, the different stoichiometries of iodine were examined (entries 2--5) and as a result, we observed a moderate increase in the yield (70%) with 1.2 equiv of iodine (entry 5). Among the solvent selection studies, ethyl acetate was found to be a better solvent than tetrahydrofuran (THF), 1,2-dichloro ethane (1,2-DCE), toluene, acetonitrile, and ethanol (entries 6--10). Noticeably, the complete conversion of **1a** (100%) was observed in ethyl acetate compared to other solvents, but the yield was not more than 70%. Therefore, we assumed that this could be due to the formation of a byproduct HI, and hence added the base (K~2~CO~3~), but the reaction yield was not improved.^[@ref18]^ Surprisingly, the introduction of ICl and NIS as alternative iodine sources did not lead to the formation of the desired compound.

###### Optimization of Reaction Conditions[a](#t1fn1){ref-type="table-fn"}

![](ao-2018-02393c_0005){#GRAPHIC-d7e248-autogenerated}

  entry   catalyst (mol %)              reaction conditions[a](#t1fn1){ref-type="table-fn"}   conversion/yield[b](#t1fn2){ref-type="table-fn"} (%)
  ------- ----------------------------- ----------------------------------------------------- ------------------------------------------------------
  1       I~2~ (2 equiv)                AcOEt,rt, 1 h                                         100 (55%)
  2       I~2~ (3 equiv)                AcOEt, rt, 1 h                                        100 (53%)
  3       I~2~ (1.5 equiv)              AcOEt, rt, 1 h                                        100 (66%)
  4       I~2~ (1 equiv)                AcOEt, rt, 1 h                                        100 (65%)
  5       I~2~ (1.2 equiv)              AcOEt, rt, 1 h                                        100 (**70**%)
  6       I~2~ (2 equiv)                THF, rt, 1 h                                          70 (50%)
  7       I~2~ (2 equiv)                1,2-DCE, rt, 1 h                                      80 (46%)
  8       I~2~ (2 equiv)                Toluene, rt, 1 h                                      80 (28%)
  9       I~2~ (2 equiv)                CH~3~CN, rt, 1 h                                      70 (40%)
  10      I~2~ (2 equiv)                EtOH, rt, 1 h                                         nr
  11      I~2~ (1.2 equiv), K~2~CO~3~   AcOEt, rt, 1 h                                        100 (65%)

3 mL of solvent used.

Isolated yields; DCE = 1,2-dichloro ethane, AcOEt = ethyl acetate; nr = no reaction.

Having the optimum conditions in hand (entry 5, [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), the generality of this synthetic process was studied with different electronic and steric influences of bisindolylmethane-tethered propargyl alcohols (**1**) bearing substitutions on the indole, propargylic positions and on alkyne have been studied. All these reactants efficiently delivered the corresponding 2-iodocarbazoles in good yields with molecular iodine ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}) in short reaction time, at room temperature in an open flask. Interestingly, the terminal position of alkyne was compatible with a variety of aryl (entries **2a**, **2b**, **2j**, **2k**, **2l**, **2o**, **2p**, **2q**, and **2t**), alkyl (entries **2c**, **2d**, **2e**, **2f**, **2g**, **2h**, **2m**, and **2n**) substitution and even hydrogen (entry **2i**). Substitution on indole was also tolerated by this protocol (entries **2o--2s**) in furnishing the desired products. Not only the 1*H*-indoles but also 1-methyl (**2j--2n**) and 1-benzyl (**2t**) substitutions on indole were proved to be compatible with this protocol. The X-ray structures of **2k** and **2t** are in agreement with the proposed ones.^[@ref19]^

###### Substrate Scope[a](#t2fn1){ref-type="table-fn"}

![](ao-2018-02393c_0006){#GRAPHIC-d7e618-autogenerated}

![](ao-2018-02393c_0007){#gr5}

All reactions were performed in 3 mL of solvent under optimized conditions as mentioned in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 5.

Encouraged by these results, we planned to substitute on the indole ring of bis(indol-3-yl)methane-tethered propargyl alcohols (**1**) a 2,4,6-trimethoxy phenyl group (assuming a similar reactivity). Furthermore, 1-(1*H*-indol-3-yl)-2,4-diphenyl-1-(2,4,6-trimethoxyphenyl)but-3-yn-2-ol (**3a**) was synthesized^[@ref20]^ and subjected to standard reaction conditions and 3-iodo-2,4-diphenyl-1-(2,4,6-trimethoxyphenyl)-9*H*-carbazole **4a** in 86% yield after 20 min was obtained. This reaction was generalized with a variety of propargyl alcohols (**3**) to obtain 3-iodocarbazoles **4b**, **4c**, and **4d** (confirmed by the X-ray structure) as depicted in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}. These results concluded that the presence of indole or trimethoxy phenyl groups on propargyl alcohols (**1** and **3**) directs the cycloisomerization through a 1,2-alkyl migration to provide 3-iodocarbazoles.

###### Substrate Scope with Trimethoxy Phenyl Substitution[a](#t3fn1){ref-type="table-fn"}

![](ao-2018-02393c_0008){#GRAPHIC-d7e680-autogenerated}

![](ao-2018-02393c_0009){#gr6}

All reactions were performed using 3 mL of solvent under standard reaction conditions as mentioned in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 5.

DFT calculations were performed to understand the nature of migration by taking the simplest substrate **1a** as the model ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).^[@ref21]^ Starting from the spirane intermediate of **1a**, it was found that **A-1a** proceeded through the preferred 1,2-alkyl migration (−4.53 kcal/mol) over the 1,2-alkenyl migration (5.45 kcal/mol). Here, in case of **A-1a**, migration proceeds through two transition states (**TS1-1a** and **TS2-1a**) separated by an intermediate local minimum (**Int-1a**). The lower activation barrier for the 1,2-alkyl migration (11.82 kcal/mol) compared to the single-step 1,2-vinyl migration (19.23 kcal/mol) leads to the formation of energetically favored product **B-1a** over **C-1a** by 9.98 kcal/mol and hence is the formation of 3-iodocarbazoles via 1,2-alkyl migration.^[@ref15],[@ref22]^

![Rationale of 1,2-alkyl versus 1,2-vinyl migration using DFT calculations.](ao-2018-02393c_0002){#fig2}

The possible reaction mechanism for the selective 1,2-alkyl migration is depicted in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. Initially, activation of the triple bond of **1** with iodine gives cyclic-iodonium intermediate-**1**. This iodonium-**1** undergoes a cascade 5-endo spirocyclization, 1,2-alkyl migration, and aromatization (loss of water) to yield a regiospecific product, 3-iodocarbazole (**2** or **4**).

![Reaction Mechanism](ao-2018-02393c_0003){#sch1}

The synthetic utility of the selected 3-iodocarbazoles is demonstrated by treating **2a** with phenylboronic acid under Suzuki cross-coupling conditions \[Pd(OAc)~2~, Na~2~CO~3~\] to obtain the 1-(1*H*-indol-3-yl)-2,3,4-triphenyl-9*H*-carbazole **5** in 80% yield.^[@ref23]^ Similarly, iodocarbazole **2j** was subjected to the Heck cross-coupling conditions with ethyl acrylate \[Pd(OAc)~2~, Bu~4~NBr, K~2~CO~3~\] and the carbazole derivative **6** in 83% yield was obtained ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref24]^

![Synthetic Transformations](ao-2018-02393c_0004){#sch2}

Conclusions {#sec3}
===========

In conclusion, we have developed an operationally simple, iodine-mediated cycloisomerization of aryl(indol-3yl)methane-tethered propargyl alcohols to the multisubstituted iodocarbazoles. We proved that both the indole and trimethoxy substituents resulted in the formation of 3-iodocarbazoles through a selective 1,2-alkyl migration. Further, we emphasized the green aspects of this method using an open-flask cascade process at room temperature, using AcOEt as the solvent, with atom and step economy. A further investigation to explore the scope of this method is currently ongoing in our laboratory.

Experimental Section {#sec4}
====================

General Remarks {#sec4.1}
---------------

Nuclear magnetic resonance (NMR) spectra for characterization of compounds were recorded on a Bruker UltraShield 500 & 400 MHz or Bruker Ascend 500 MHz instrument (^1^H) at 125 & 100 MHz (^13^C). Chemical shifts (δ) are reported in ppm, using the residual solvent peak in CDCl~3~ (δ~H~ = 7.26 and δ~C~ = 77.16 ppm) as internal reference and coupling constants (*J*) are given in hertz. The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet. High-resolution mass spectra (HRMS) were recorded using Bruker-maXis (ESI-TOF) mass spectrometer (ESI-MS) and CHN analysis was recorded using EA 1112 series, Thermo Finnigan. Melting points were measured with a MEPA LABINDIA melting point apparatus. Single-crystal X-ray diffraction data were collected in Bruker D8-Quest, Rigaku Oxford, and Bruker Apex-3 diffractometers. The structures were solved with direct methods using the SHELXL programs and refined with full-matrix least-squares on *F*^2^. Nonhydrogen atoms were refined anisotropically. Unless mentioned, reactions were performed in open atmosphere at room temperature in a 25 mL round-bottom flask. Thin-layer chromatography (TLC) carried out on Merck silica plates (60F-254) and components was visualized by observation under UV light or by treating the plates with β-naphthol followed by heating. Flash silica gel chromatography was performed using silica gel (60--120 mesh).

Starting materials **1a** to **1t** and **3a** to **3d** were prepared using the reported methods.^[@ref15],[@ref20]^

### Synthesis of 1,1-Di(1*H*-indol-3-yl)-2-phenylnon-3-yn-2-ol (**1d**) {#sec4.1.1}

Brown solid (0.294 g, 77% yield); mp: 162--163 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.01 (s, 1H), 7.89 (s, 1H), 7.64 (d, *J* = 8.5 Hz, 2H), 7.56 (d, *J* = 7.5 Hz, 1H), 7.46 (t, *J* = 7 Hz, 1H), 7.37 (d, *J* = 6.5 Hz, 1H), 7.26--7.22 (m, 2H), 7.19--7.14 (m, 3H), 7.11--7.07 (m, 3H), 7.02 (t, *J* = 8 Hz, 2H), 6.85 (s, 1H), 5.16 (s, 1H), 2.19 (t, *J* = 7 Hz, 2H), 1.46--1.42 (m, 2H), 1.27--1.25 (m, 4H), 0.85 (t, *J* = 7 Hz, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 144.1, 135.8, 135.6, 134.0, 129.6, 128.6, 128.3, 128.0, 127.6, 126.5, 123.8, 121.9, 121.6, 119.6, 119.5, 119.1, 115.9, 115.5, 111.0, 110.7, 88.2, 83.4, 76.4, 47.1, 31.2, 28.2, 22.2, 19.0, 14.1 ppm. Anal. Calcd for C~31~H~30~N~2~O: C, 83.37; H, 6.77; N, 6.27. Found: C, 83.23; H, 6.71; N, 6.32. EI-LRMS *m*/*z*: calcd for C~31~H~31~N~2~O \[M + 1\], 447; found, 447.

### Synthesis of 1,1-Di(1*H*-indol-3-yl)-2-phenyldec-3-yn-2-ol (**1e**) {#sec4.1.2}

Brown solid (0.36 g, 91% yield); mp: 63--64 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.02 (s, 1H), 7.89 (s, 1H), 7.64 (d, *J* = 8.5 Hz, 2H), 7.57 (d, *J* = 8 Hz, 1H), 7.39 (s, 1H), 7.26--7.23 (m, 4H), 7.15 (d, *J* = 7.5 Hz, 2H), 7.10 (t, *J* = 7.5 Hz, 2H), 7.04--6.98 (m, 3H), 6.87 (t, *J* = 7.5 Hz, 1H), 5.16 (s, 1H), 2.20 (t, *J* = 7 Hz, 2H), 1.47--1.42 (m, 3H), 1.30--1.24 (m, 5H), 0.87 (t, *J* = 7 Hz, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 144.1, 135.9, 135.6, 134.0, 129.7, 128.6, 128.3, 128.0, 127.6, 127.3, 126.5, 124.3, 123.8, 122.0, 121.6, 119.5, 119.4, 119.1, 116.0, 115.6, 111.0, 110.7, 88.2, 83.4, 76.4, 47.1, 31.4, 28.7, 28.6, 22.6, 19.1, 14.1 ppm. Anal. Calcd for C~32~H~32~N~2~O: C, 83.44; H, 7.00; N, 6.08. Found: C, 83.32; H, 6.91; N, 6.15. EI-LRMS *m*/*z*: calcd for C~32~H~33~N~2~O \[M + 1\], 461; found, 461.

### Synthesis of 4-Cyclopropyl-1,1-di(1*H*-indol-3-yl)-2-phenylbut-3-yn-2-ol (**1g**) {#sec4.1.3}

Brown solid (0.576 g, 97% yield); mp: 77--79 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.04 (s, 1H), 7.92 (s, 1H), 7.62 (d, *J* = 8.5 Hz, 2H), 7.56 (d, *J* = 7.5 Hz, 1H), 7.39 (s, 1H), 7.28--7.25 (m, 3H), 7.21 (d, *J* = 8.5 Hz, 1H), 7.17--7.14 (m, 3H), 7.13--7.09 (m, 2H), 7.05--6.98 (m, 2H), 6.87 (t, *J* = 9 Hz, 1H), 5.15 (s, 1H), 1.03--1.02 (m, 1H), 0.72--0.70 (m, 2H), 0.59--0.54 (m, 2H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 143.9, 135.8, 135.5, 133.9, 129.5, 128.5, 128.3, 128.0, 127.7, 127.3, 126.5, 123.8, 123.0, 122.0, 121.6, 119.5(2), 119.4, 119.1, 116.0, 115.4, 110.9, 110.7, 90.9, 78.6, 76.3, 47.1, 10.0, 8.1 ppm. Anal. Calcd for C~29~H~24~N~2~O: C, 83.63; H, 5.81; N, 6.73. Found: C, 83.55; H, 5.75; N, 6.79. EI-LRMS *m*/*z*: calcd for C~29~H~25~N~2~O \[M + 1\], 417; found, 417.

### Synthesis of 1,1-Bis(1-methyl-1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)but-3-yn-2-ol (**1k**) {#sec4.1.4}

Brown solid (0.21 g, 80% yield); mp: 186--187 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 7.69 (d, *J* = 7.2 Hz, 2H), 7.61 (t, *J* = 8 Hz, 2H), 7.40 (s, 1H), 7.36--7.08 (m, 12H), 7.04 (t, *J* = 7.2 Hz, 2H), 7.85 (t, *J* = 6.8 Hz, 1H), 5.24 (s, 1H), 3.71 (s, 3H), 3.65 (s, 3H), 2.34 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 143.5, 138.6, 136.6, 136.2, 131.5, 129.6, 129.1, 128.8, 128.5, 128.4, 128.3, 127.7, 127.5, 126.6, 121.6, 121.1, 119.9, 119.4, 119.3, 119.1, 118.6, 114.2, 113.8, 109.1, 108.7, 100.0, 92.0, 87.2, 76.8, 47.2, 33.0, 32.9, 21.6 ppm. Anal. Calcd for C~35~H~30~N~2~O: C, 84.99; H, 6.11; N, 5.66. Found: C, 84.91; H, 6.15; N, 5.58. EI-LRMS *m*/*z*: calcd for C~35~H~29~N~2~O \[M -- 1\], 493; found, 493.

### Synthesis of 1,1-Bis(1-methyl-1*H*-indol-3-yl)-2-phenyl-4-(4-propylphenyl)but-3-yn-2-ol (**1l**) {#sec4.1.5}

Brown solid (116 mg, 84% yield); mp: 193--194 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 7.69 (d, *J* = 8 Hz, 2H), 7.62 (d, *J* = 8 Hz, 1H), 7.41 (s, 1H), 7.27 (d, *J* = 7 Hz, 2H), 7.24--7.11 (m, 9H), 7.08--7.01 (m, 3H), 6.85 (t, *J* = 7.5 Hz, 1H), 5.23 (s, 1H), 3.73 (s, 3H), 3.67 (s, 3H), 3.18 (s, 1H), 2.58 (t, *J* = 7.5 Hz, 2H), 1.67--1.60 (m, 2H), 0.93 (t, *J* = 7.5 Hz, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 143.7, 143.4, 136.7, 136.4, 131.6, 128.9, 128.6, 128.5, 128.4, 127.7, 127.5, 126.7, 121.7, 121.2, 120.3, 119.5, 119.4, 119.2, 118.7, 114.4, 114.0, 109.1, 108.7, 92.3, 87.4, 76.9, 47.3, 38.1, 33.0, 32.9, 24.4, 13.8 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~37~H~34~N~2~NaO \[M + Na\]^+^, 545.2569; found, 545.2569.

### Synthesis of 1,1-Bis(1-methyl-1*H*-indol-3-yl)-2-phenyldec-3-yn-2-ol (**1n**) {#sec4.1.6}

Sticky brown solid (0.257 g, 66% yield); ^1^H NMR (400 MHz, CDCl~3~): δ 7.62 (d, *J* = 8 Hz, 2H), 7.55 (d, *J* = 8 Hz, 1H), 7.27 (s, 1H), 7.21 (d, *J* = 7 Hz, 1H), 7.14--7.11 (m, 4H), 7.09--7.03 (m, 5H), 7.03 (t, *J* = 7.6 Hz, 2H), 5.13 (s, 1H), 3.58 (s, 3H), 3.54 (s, 3H), 3.21 (t, *J* = 6.8 Hz, 2H), 1.47--1.43 (m, 2H), 1.32--1.22 (m, 6H), 0.86 (t, *J* = 6.8 Hz, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 144.0, 136.5, 136.2, 128.7, 128.4, 128.3, 127.5, 127.2, 126.5, 121.4, 121.0, 119.4, 119.2, 118.9, 118.4, 114.4, 113.9, 108.9, 108.6, 87.8, 83.5, 76.4, 47.0, 32.7, 32.6, 31.4, 28.6, 28.5, 22.5, 19.0, 14.1 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~34~H~36~N~2~NaO \[M + Na\]^+^, 511.2726; found, 511.2725.

### Synthesis of 1,1-Bis(5-bromo-1*H*-indol-3-yl)-2,4-diphenylbut-3-yn-2-ol (**1o**) {#sec4.1.7}

Sticky brown solid (0.223 g, 93% yield); ^1^H NMR (500 MHz, CDCl~3~): δ 8.13 (s, 1H), 8.06 (s, 1H), 7.61--7.60 (m, 3H), 7.45 (d, *J* = 6.5 Hz, 1H), 7.37 (t, *J* = 7.5 Hz, 3H), 7.32--7.26 (m, 5H), 7.15--7.13 (m, 2H), 7.08--7.04 (m, 2H), 7.02 (d, *J* = 9 Hz, 2H), 6.73 (s, 1H), 5.03 (s, 1H) ppm; ^13^C NMR (125 MHz, CDCl~3~): δ 143.2, 139.0, 136.2, 135.2, 134.5, 134.2, 132.2, 132.1, 131.7, 129.7, 129.1, 128.9, 128.5, 127.9, 126.4, 125.3, 125.0, 124.6, 122.4, 122.0, 121.4, 114.8, 114.4, 113.3, 113.1, 113.0, 112.6, 112.4, 92.0, 87.6, 76.7, 47.5 ppm. Anal. Calcd for C~32~H~22~Br~2~N~2~O: C, 62.97; H, 3.63; N, 4.59. Found: C, 62.85; H, 3.68; N, 4.52. EI-LRMS *m*/*z*: calcd for C~32~H~23~Br~2~N~2~O \[M + 1\], 609; found, 609.

### Synthesis of 1,1-Bis(5-methoxy-1*H*-indol-3-yl)-2,4-diphenylbut-3-yn-2-ol (**1p**) {#sec4.1.8}

Brown solid (0.325 g, 87% yield); mp: 121--122 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 7.86 (s, 1H), 7.68 (s, 1H), 7.67 (d, *J* = 9.5 Hz, 2H), 7.52 (s, 2H), 7.35--7.33 (m, 3H), 7.29--7.28 (m, 3H), 7.18--7.15 (m, 3H), 7.08 (d, *J* = 8.5 Hz, 2H), 6.99 (s, 1H), 6.78 (d, *J* = 9 Hz, 1H), 6.69 (d, *J* = 9 Hz, 1H), 6.59 (s, 1H), 5.27 (s, 1H), 3.71 (s, 3H), 3.59 (s, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 154.3, 154.1, 153.8, 143.6, 133.2, 132.1, 131.7, 131.1, 130.8, 129.7, 129.1, 128.8, 128.5, 128.4, 127.8, 127.7, 126.7, 124.8, 124.4, 122.9, 115.4, 115.0, 112.2, 111.8, 111.7, 111.4, 101.6, 101.2, 92.7, 87.2, 76.5, 56.0, 55.8, 47.6 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~34~H~28~N~2~NaO~3~ \[M + Na\]^+^, 535.1997; found, 535.1994.

### Synthesis of 1,1-Bis(5-methoxy-1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)but-3-yn-2-ol (**1q**) {#sec4.1.9}

Brown solid (0.216 g, 55% yield); mp: 93--94 °C; ^1^H NMR (400 MHz, CDCl~3~): δ 7.98 (s, 1H), 7.83 (s, 1H), 7.66 (d, *J* = 8 Hz, 2H), 7.41 (s, 1H), 7.49 (s, 1H), 7.37 (d, *J* = 8 Hz, 1H), 7.26--7.21 (m, 3H), 7.12--6.99 (m, 6H), 6.83--6.75 (m, 2H), 6.68 (d, *J* = 7.6 Hz, 1H), 6.60 (s, 1H), 5.08 (s, 1H), 3.70 (s, 3H), 3.59 (s, 3H), 2.32 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 154.2, 154.0, 153.7, 143.6, 138.7, 132.1, 131.6, 131.1, 130.7, 129.1, 128.7, 128.4, 127.8, 127.6, 127.1, 126.7, 124.8, 124.4, 119.8, 115.3, 115.0, 112.2, 112.1, 111.7, 111.4, 91.9, 87.3, 76.5, 55.9, 55.8, 47.5, 21.5 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~35~H~30~N~2~NaO~3~ \[M + Na\]^+^, 549.2154; found, 549.2157.

### Synthesis of 2-(4-Chlorophenyl)-1,1-di(1*H*-indol-3-yl)-4-phenylbut-3-yn-2-ol (**1r**) {#sec4.1.10}

Brown solid (0.134 g, 71% yield); mp: 162--163 °C; ^1^H NMR (500 MHz, CDCl~3~): δ 8.10 (s, 1H), 7.97 (s, 1H), 7.62--7.61 (m, 3H), 7.51 (s, 1H), 7.34 (d, *J* = 6.5 Hz, 2H), 7.32--7.28 (m, 5H), 7.16--7.04 (m, 4H), 7.07--7.04 (m, 3H), 6.91 (t, *J* = 7 Hz, 2H), 5.21 (s, 1H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 142.1, 135.9, 135.6, 133.4, 133.2, 131.7, 131.6, 131.0, 129.6, 128.8, 128.7, 128.4, 128.1, 127.9, 123.8, 123.7, 122.7(2), 121.9, 119.8, 119.4, 119.3, 119.2, 115.4, 115.0, 111.1, 110.9, 92.2, 87.4, 76.6, 63.8, 47.3 ppm. Anal. Calcd for C~32~H~23~ClN~2~O: C, 78.92; H, 4.76; N, 5.75. Found: C, 78.82; H, 4.81; N, 5.69. EI-LRMS *m*/*z*: calcd for C~32~H~24~ClN~2~O \[M + 1\], 487; found, 487.

### Synthesis of 1,1-Bis(1-benzyl-5-methoxy-1*H*-indol-3-yl)-2,4-diphenylbut-3-yn-2-ol (**1t**) {#sec4.1.11}

Sticky brown solid (0.256 g, 95% yield); ^1^H NMR (500 MHz, CDCl~3~): δ 7.67 (d, *J* = 8 Hz, 2H), 7.42 (s, 1H), 7.27 (d, *J* = 8.5 Hz, 2H), 7.20--7.14 (m, 10H), 7.15 (d, *J* = 7.5 Hz, 4H), 7.06 (d, *J* = 9 Hz, 3H), 6.98 (d, *J* = 8 Hz, 3H), 6.93 (d, *J* = 6.5 Hz, 2H), 6.76 (d, *J* = 8.5 Hz, 1H), 6.68 (t, *J* = 8.5 Hz, 2H), 5.20 (d, *J* = 5.5 Hz, 2H), 5.13 (d, *J* = 5.5 Hz, 2H), 3.70 (s, 3H), 3.56 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 154.0, 153.7, 143.5, 147.9, 137.7, 132.7, 131.7, 131.6, 161.3, 129.5, 129.1, 129.0, 128.8, 128.7, 128.6, 128.5, 128.4, 128.3, 127.8, 127.6(2), 127.5, 126.7(2), 126.6, 122.8, 114.3, 113.8, 111.9, 111.6, 110.4, 110.0, 101.8, 101.5, 92.5, 87.2, 76.8, 55.9, 55.8, 50.3, 50.1, 47.7 ppm. Anal. Calcd for C~48~H~40~N~2~O~3~: C, 83.21; H, 5.82; N, 4.04. Found: C, 83.55; H, 5.75; N, 4.23. EI-LRMS *m*/*z*: calcd for C~48~H~40~N~2~O~3~ \[M\], 692; found, 692.

General Procedure for the Synthesis of 3-Iodocarbazoles **2** and **4** {#sec4.2}
-----------------------------------------------------------------------

Molecular iodine (1.2 equiv) was added to a stirred solution of **1** & **3** (1.0 equiv) in ethyl acetate (3 mL). The resulting mixture was stirred at room temperature until **1** & **3** was consumed as determined by TLC. The reaction was quenched with a saturated aqueous solution of Na~2~S~2~O~3~ and extracted with EtOAc (3 × 10 mL). The combined organic layers were dried over anhydrous Na~2~SO~4~ and concentrated at reduced pressure. The residue was purified by flash chromatography on deactivated silica gel (60--120 mesh) using mixtures of hexane and EtOAc as eluents to obtain the corresponding products **2**& **4**.

### Synthesis of 1-(1*H*-Indol-3-yl)-3-iodo-2,4-diphenyl-9*H*-carbazole (**2a**) {#sec4.2.1}

The reaction of 1,1-di(1*H*-indol-3-yl)-2,4-diphenylbut-3-yn-2-ol (**1a**) (159 mg, 0.35 mmol) and molecular iodine (107 mg, 0.42 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (138 mg, 70% yield, mp = 220--221 °C).^1^H NMR (500 MHz, CDCl~3~): δ 8.00 (s, 1H), 7.91 (s, 1H), 7.53--7.50 (m, 3H), 7.42 (d, *J* = 8 Hz, 1H), 7.37 (t, *J* = 7 Hz, 2H), 7.34--7.26 (m, 3H), 7.18--7.16 (m, 2H), 7.11--7.10 (m, 2H), 7.04 (t, *J* = 8 Hz, 1H), 6.97 (t, *J* = 8 Hz, 1H), 6.86--6.82 (m, 2H), 6.65 (s, 1H), 6.54 (d, *J* = 8 Hz, 1H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 145.9, 145.0, 143.5, 140.7, 139.7, 139.1, 135.7, 131.6, 129.7, 129.6, 129.5, 128.9, 128.0, 27.9, 127.1, 126.9, 126.7, 126.0, 125.0, 123.1, 122.5 (3C), 121.8, 120.3, 120.0, 119.5, 116.9, 112.4, 111.5, 110.6, 96.3 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~32~H~21~IKN~2~ \[M + K\]^+^, 599.0386; found, 599.0366.

### Synthesis of 1-(1*H*-Indol-3-yl)-3-iodo-2-phenyl-4-(*p*-tolyl)-9*H*-carbazole (**2b**) {#sec4.2.2}

The reaction of 1,1-di(1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)but-3-yn-2-ol (**1b**) (150 mg, 0.32 mmol) and molecular iodine (97 mg, 0.38 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (125 mg, 68% yield, mp = 140--141 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 8.00 (s, 1H), 7.98 (s, 1H), 7.45--7.39 (m, 5H), 7.37--7.34 (m, 3H), 7.28--7.25 (m, 2H), 7.20--7.18 (m, 2H), 7.12 (t, *J* = 8 Hz, 1H), 7.05 (t, *J* = 7.5 Hz, 1H), 6.94--6.90 (m, 2H), 6.73 (s, 1H), 6.69 (d, *J* = 8 Hz, 1H), 2.54 (s, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 146.0, 143.4, 142.1, 140.8, 139.7, 139.1, 137.7, 135.6, 131.6, 129.7, 129.5, 129.2, 128.6, 128.5, 127.9, 127.0, 126.8, 126.7, 126.0, 125.0, 123.1, 122.6, 122.4, 121.9, 120.3, 120.0, 119.5, 116.8, 112.4, 111.5, 110.5, 96.7, 21.7 ppm. Anal. Calcd for C~33~H~23~IN~2~: C, 69.00; H, 4.04; N, 4.88. Found: C, 69.16; H, 4.09; N, 4.82. EI-LRMS *m*/*z*: calcd for C~33~H~22~IN~2~ \[M -- 1\], 573; found, 573. HRMS (ESI-TOF) *m*/*z*: calcd for C~33~H~23~IN~2~Na \[M + Na\]^+^, 597.0803; found, 597.0803.

### Synthesis of 4-Butyl-1-(1*H*-indol-3-yl)-3-iodo-2-phenyl-9*H*-carbazole (**2c**) {#sec4.2.3}

The reaction of 1,1-di(1*H*-indol-3-yl)-2-phenyloct-3-yn-2-ol (**1c**) (94 mg, 0.21 mmol) and molecular iodine (66 mg, 0.26 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (76 mg, 65% yield, mp = 106--107 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 8.14 (d, *J* = 8 Hz, 1H), 8.05 (s, 1H), 7.94 (s, 1H), 7.39--7.26 (m, 6H), 7.24--7.15 (m, 3H), 7.07 (t, *J* = 7.5 Hz, 1H), 7.02 (t, *J* = 7.5 Hz, 1H), 6.86 (d, *J* = 7.5 Hz, 1H), 6.65 (s, 1H), 3.56 (t, *J* = 6.5 Hz, 2H), 1.89--1.86 (m, 2H), 1.12--1.09 (m, 2H), 1.11 (t, *J* = 7 Hz, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 146.5, 144.0, 140.1, 139.7, 139.4, 135.6, 131.5, 129.4, 127.8, 127.0, 126.7 (2C), 125.7, 125.0, 123.0, 122.8, 122.3, 120.7, 120.2, 119.9, 119.8, 115.5, 112.4, 111.5, 110.9, 97.9, 40.1, 30.7, 23.4, 14.2 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~30~H~25~IN~2~Na \[M + Na\]^+^, 563.0960; found, 563.0965.

### Synthesis of 1-(1*H*-Indol-3-yl)-3-iodo-4-pentyl-2-phenyl-9*H*-carbazole (**2d**) {#sec4.2.4}

The reaction of 1,1-di(1*H*-indol-3-yl)-2-phenylnon-3-yn-2-ol (**1d**) (112 mg, 0.25 mmol) and molecular iodine (76 mg, 0.3 mmol), in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (75 mg, 54% yield, mp = 118--119 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 8.07 (d, *J* = 8 Hz, 1H), 8.02 (s, 1H), 7.90 (s, 1H), 7.32--7.28 (m, 3H), 7.26 (d, *J* = 8 Hz, 2H), 7.23--7.20 (m, 2H), 7.15 (t, *J* = 7 Hz, 1H), 7.11 (t, *J* = 7 Hz, 1H), 7.01 (t, *J* = 7 Hz, 1H), 6.97 (t, *J* = 7.5 Hz, 1H), 6.80 (d, *J* = 8.5 Hz, 1H), 6.62 (s, 1H), 3.49 (t, *J* = 6 Hz, 2H), 1.84--1.80 (m, 2H), 1.63--1.58 (m, 2H), 1.47--1.43 (m, 2H), 0.93 (t, *J* = 7.5 Hz, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 146.5, 144.0, 140.2, 139.7, 139.4, 135.6, 131.5, 129.4, 127.8, 127.0, 126.8, 126.7, 125.7, 125.0, 123.1, 122.8, 122.4, 120.8, 120.2, 120.0, 119.8, 115.5, 112.5, 111.5, 110.9, 97.8, 40.4, 32.5, 28.3, 22.8, 14.3 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~31~H~28~IN~2~ \[M + H\]^+^, 555.1317; found, 555.1295.

### Synthesis of 4-Hexyl-1-(1*H*-indol-3-yl)-3-iodo-2-phenyl-9*H*-carbazole (**2e**) {#sec4.2.5}

The reaction of 1,1-di(1*H*-indol-3-yl)-2-phenyldec-3-yn-2-ol (**1e**) (83 mg, 0.18 mmol) and molecular iodine (54 mg, 0.21 mmol), in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (53 mg, 52% yield, mp = 82--83 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 8.14 (d, *J* = 8 Hz, 1H), 8.09 (s, 1H), 7.96 (s, 1H), 7.39--7.32 (m, 3H), 7.32 (d, *J* = 7.5 Hz, 2H), 7.28 (t, *J* = 8 Hz, 2H), 7.22 (s, 1H), 7.18 (t, *J* = 7.5 Hz, 1H), 7.09 (d, *J* = 7 Hz, 1H), 7.06--7.03 (m, 1H), 6.87 (d, *J* = 8 Hz, 1H), 6.69 (s, 1H), 3.56 (t, *J* = 8.5 Hz, 2H), 1.90 (t, *J* = 7.5 Hz, 2H), 1.70--1.69 (m, 2H), 1.48--1.40 (m, 4H), 0.95 (t, *J* = 7.5 Hz, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 146.5, 144.1, 140.2, 139.8, 139.5, 135.7, 131.6, 129.5, 127.8, 127.0, 126.8 (2C), 125.7, 125.0, 123.1, 122.8, 122.4, 120.8, 120.3, 120.0, 119.9, 115.5, 112.5, 111.5, 110.9, 97.9, 40.4, 31.9, 30.0, 28.6, 22.8, 14.2 ppm. Anal. Calcd for C~32~H~29~IN~2~: C, 67.61; H, 5.14; N, 4.93. Found: C, 67.45; H, 5.21; N, 4.85. EI-LRMS *m*/*z*: calcd for C~32~H~28~IN~2~ \[M -- 1\], 567; found, 567.

### Synthesis of 1-(1*H*-Indol-3-yl)-3-iodo-2-phenyl-4-(3-phenylpropyl)-9*H*-carbazole (**2f**) {#sec4.2.6}

The reaction of 1,1-di(1*H*-indol-3-yl)-2,7-diphenylhept-3-yn-2-ol (**1f**) (118 mg, 0.23 mmol) and molecular iodine (72 mg, 0.28 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (90 mg, 63% yield, mp = 211--212 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 8.02 (s, 1H), 7.91 (s, 1H), 7.66 (d, *J* = 8 Hz, 1H), 7.36--7.32 (m, 7H), 7.30--7.26 (m, 3H), 7.23--7.15 (m, 3H), 7.12 (t, *J* = 7 Hz, 1H), 7.08 (t, *J* = 7.5 Hz, 1H), 7.02 (t, *J* = 7.5 Hz, 1H), 6.85 (d, *J* = 7.5 Hz, 1H), 6.65 (s, 1H), 3.58 (t, *J* = 7.5 Hz, 2H), 2.99 (t, *J* = 7 Hz, 2H), 2.22--2.16 (m, 2H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 146.4, 144.0, 142.1, 139.6 (2C), 139.4, 135.6, 131.5, 129.4, 129.0, 128.5, 127.8, 127.0, 126.8, 126.7, 126.1, 125.7, 124.9, 122.9, 122.7, 122.4, 120.7, 120.2, 119.9, 119.8, 115.6, 112.4, 111.5, 110.8, 98.0, 39.7, 36.4, 30.1 ppm. Anal. Calcd for C~35~H~27~IN~2~: C, 69.77; H, 4.52; N, 4.65. Found: C, 69.85; H, 4.48; N, 4.61. EI-LRMS *m*/*z*: calcd for C~35~H~28~IN~2~ \[M + 1\], 603; found, 603.

### Synthesis of 4-Cyclopropyl-1-(1*H*-indol-3-yl)-3-iodo-2-phenyl-9*H*-carbazole (**2g**) {#sec4.2.7}

The reaction of 4-cyclopropyl-1,1-di(1*H*-indol-3-yl)-2-phenylbut-3-yn-2-ol (**1g**) (150 mg, 0.36 mmol) and molecular iodine (110 mg, 0.43 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (113 mg, 59% yield, mp \>300 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 8.58 (d, *J* = 8.5 Hz, 1H), 8.09 (s, 1H), 7.96 (s, 1H), 7.40--7.32 (m, 3H), 7.29--7.28 (m, 2H), 7.23 (t, *J* = 7 Hz, 2H), 7.19 (t, *J* = 7 Hz, 2H), 7.09 (d, *J* = 7 Hz, 1H), 7.05 (t, *J* = 7.5 Hz, 1H), 6.86 (d, *J* = 8 Hz, 1H), 6.69 (s, 1H), 2.42--2.39 (m, 1H), 1.00--0.97 (m, 2H), 0.88--0.85 (m, 2H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 146.2, 144.0, 139.8, 139.5, 139.4, 135.6, 131.7, 129.5, 127.8, 126.9, 126.8, 126.7, 125.7, 125.0, 124.9, 123.5, 122.8, 122.4, 120.3, 120.0, 119.3, 115.9, 112.4, 111.5, 110.5, 99.7, 20.8, 13.5 ppm. Anal. Calcd for C~29~H~21~IN~2~: C, 66.42; H, 4.04; N, 5.34. Found: C, 66.32; H, 4.09; N, 5.38. EI-LRMS *m*/*z*: calcd for C~29~H~22~IN~2~ \[M + 1\], 525; found, 525.

### Synthesis of 4-Cyclohexyl-1-(1*H*-indol-3-yl)-3-iodo-2-phenyl-9*H*-carbazole (**2h**) {#sec4.2.8}

The reaction of 4-cyclohexyl-1,1-di(1*H*-indol-3-yl)-2-phenylbut-3-yn-2-ol (**1h**) (103 mg, 0.22 mmol) and molecular iodine (68 mg, 0.27 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a  sticky brown solid (71 mg, 56% yield). ^1^H NMR (500 MHz, CDCl~3~): δ 8.60 (d, *J* = 8 Hz, 1H), 7.93 (s, 2H), 7.27--7.21 (m, 4H), 7.19--7.11 (m, 2H), 7.16--7.11 (m, 2H), 7.07 (t, *J* = 7.5 Hz, 1H), 6.98 (t, *J* = 7.5 Hz, 1H), 7.93 (t, *J* = 8 Hz, 1H), 6.78 (d, *J* = 7.5 Hz, 1H), 6.58 (s, 1H), 4.00--3.95 (m, 1H), 2.67--2.62 (m, 2H), 1.99--1.97 (m, 2H), 1.69--1.63 (m, 4H), 1.58--1.53 (m, 2H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 147.4, 144.6, 144.0, 140.4, 139.8, 135.6, 131.4, 129.2, 127.8, 127.1, 126.9, 126.7, 125.3, 125.0, 122.4, 121.8, 120.2, 120.0, 119.0, 116.0, 112.4, 111.4, 110.9, 100.0, 52.7, 26.8, 26.7, 26.6(2), 25.3 ppm. Anal. Calcd for C~32~H~27~IN~2~: C, 67.85; H, 4.80; N, 4.95. Found: C, 67.72; H, 4.75; N, 5.02. EI-LRMS *m*/*z*: calcd for C~32~H~26~IN~2~ \[M -- 1\], 565; found, 565. HRMS (ESI-TOF) *m*/*z*: calcd for C~32~H~27~IN~2~Na \[M + Na\]^+^, 589.1116; found, 589.1119.

### Synthesis of 1-(1*H*-Indol-3-yl)-3-iodo-2-phenyl-9*H*-carbazole (**2i**) {#sec4.2.9}

The reaction of 1,1-di(1*H*-indol-3-yl)-2-phenylbut-3-yn-2-ol (**1i**) (100 mg, 0.26 mmol) and molecular iodine (80 mg, 0.31 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a pale white solid (76 mg, 60% yield, mp = 86--87 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 8.66 (s, 1H), 8.08--8.02 (m, 2H), 7.87 (s, 1H), 7.37--7.32 (m, 5H), 7.24--7.18 (m, 3H), 7.16 (t, *J* = 7.6 Hz, 1H), 7.09 (t, *J* = 7.2 Hz, 1H), 7.03 (t, *J* = 7.2 Hz, 1H), 6.86 (d, *J* = 8 Hz, 1H), 6.66 (s, 1H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 144.9, 142.6, 139.7, 139.3, 135.6, 131.4, 129.5, 129.4, 127.8, 127.5, 127.1, 126.9, 126.6, 126.5, 125.0, 124.4, 122.4, 122.3, 120.6, 120.4, 119.9, 118.0, 112.3, 111.5, 110.9, 89.2 ppm. Anal. Calcd for C~26~H~17~IN~2~: C, 64.48; H, 3.54; N, 5.78. Found: C, 64.32; H, 3.51; N, 5.82. EI-LRMS *m*/*z*: calcd for C~26~H~18~IN~2~ \[M + 1\], 485; found, 485.

### Synthesis of 3-Iodo-9-methyl-1-(1-methyl-1*H*-indol-3-yl)-2,4-diphenyl-9*H*-carbazole (**2j**) {#sec4.2.10}

The reaction of 1,1-bis(1-methyl-1*H*-indol-3-yl)-2,4-diphenylbut-3-yn-2-ol (**1j**) (100 mg, 0.20 mmol) and molecular iodine (65 mg, 0.25 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (99 mg, 81% yield, mp = 209--210 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 7.62--7.59 (m, 3H), 7.49 (d, *J* = 8 Hz, 1H), 7.44 (d, *J* = 6.8 Hz, 1H), 7.34 (t, *J* = 7.2 Hz, 1H), 7.27--7.20 (m, 6H), 7.08--7.04 (m, 2H), 6.93--6.90 (m, 2H), 6.84 (d, *J* = 8 Hz, 1H), 6.63 (s, 1H), 6.55 (d, *J* = 8 Hz, 1H), 3.66 (s, 3H), 3.18 (s, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 146.4, 145.9, 145.2, 142.9, 142.6, 140.9, 140.3, 136.0, 131.0, 130.4, 129.7, 129.5, 129.4, 129.2, 129.0, 128.5, 128.0, 127.3 (2C), 126.8, 126.5, 125.9, 122.5, 121.8, 120.3, 119.7, 119.2, 117.1, 112.6, 109.1, 108.7, 95.9, 32.8, 31.1 ppm. Anal. Calcd for C~34~H~25~IN~2~: C, 69.39; H, 4.28; N, 4.76. Found: C, 69.48; H, 4.23; N, 4.81. EI-LRMS *m*/*z*: calcd for C~34~H~24~IN~2~ \[M -- 1\], 587; found, 587. HRMS (ESI-TOF) *m*/*z*: calcd for C~34~H~25~IN~2~Na \[M + Na\]^+^, 611.0960; found, 563.0963.

### Synthesis of 3-Iodo-9-methyl-1-(1-methyl-1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)-9*H*-carbazole (**2k**) {#sec4.2.11}

The reaction of 1,1-bis(1-methyl-1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)but-3-yn-2-ol (**1k**) (100 mg, 0.20 mmol) and molecular iodine (61 mg, 0.24 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a white solid (101 mg, 83% yield, mp = 186--187 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 7.42 (t, *J* = 6 Hz, 2H), 7.37--7.31 (m, 3H), 7.27--7.17 (m, 6H), 7.07 (d, *J* = 7.5 Hz, 1H), 7.04 (t, *J* = 6.5 Hz, 1H), 6.91 (d, *J* = 8 Hz, 2H), 6.83 (d, *J* = 7.5 Hz, 1H), 6.61 (s, 2H), 3.64 (s, 3H), 3.17 (s, 3H), 2.53 (s, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 146.5, 145.8, 142.6, 142.3, 140.9, 140.2, 137.6, 135.9, 130.9, 130.4, 129.7, 129.4 (2C), 129.3, 129.2, 127.3, 126.8, 126.4, 125.9, 122.5, 122.3, 121.7, 120.3, 119.7, 119.1, 117.0, 112.6, 109.1, 108.7, 96.4, 32.8, 31.1, 21.7 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~35~H~28~IN~2~ \[M + H\]^+^, 603.1296; found, 603.1293.

### Synthesis of 3-Iodo-9-methyl-1-(1-methyl-1*H*-indol-3-yl)-2-phenyl-4-(4-propylphenyl)-9*H*-carbazole (**2l**) {#sec4.2.12}

The reaction of 1,1-bis(1-methyl-1*H*-indol-3-yl)-2-phenyl-4-(4-propylphenyl)but-3-yn-2-ol (**1l**) (100 mg, 0.19 mmol) and molecular iodine (58 mg, 0.22 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a pale white solid (85 mg, 71% yield, mp = 240--241 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 7.41--7.33 (m, 5H), 7.28--7.19 (m, 6H), 7.02 (t, *J* = 6.8 Hz, 2H), 6.90 (t, *J* = 6.4 Hz, 2H), 6.84 (d, *J* = 7.2 Hz, 1H), 6.61 (s, 1H), 6.55 (d, *J* = 7.6 Hz, 1H), 3.64 (s, 3H), 3.17 (s, 3H), 2.77 (t, *J* = 7.6 Hz, 2H), 1.84--1.78 (m, 2H), 1.05 (t, *J* = 7.2 Hz, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 146.5, 145.8, 142.6, 142.5, 142.4, 141.0, 140.2, 135.9, 130.9, 130.4, 129.4, 129.3, 129.2, 129.1, 127.3, 126.7, 126.4, 125.9, 122.6, 122.5, 122.3, 121.7, 120.3, 119.7, 119.1, 116.9, 112.6, 109.1, 108.6, 96.2, 38.1, 32.8, 31.1, 24.6, 13.9 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~37~H~32~IN~2~ \[M + H\]^+^, 631.1610; found, 631.1609.

### Synthesis of 4-Cyclopropyl-3-iodo-9-methyl-1-(1-methyl-1*H*-indol-3-yl)-2-phenyl-9*H*-carbazole (**2m**) {#sec4.2.13}

The reaction of 4-cyclopropyl-1,1-bis(1-methyl-1*H*-indol-3-yl)-2-phenylbut-3-yn-2-ol (**1m**) (56 mg, 0.12 mmol) and molecular iodine (38 mg, 0.15 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a sticky brown solid (43 mg, 61% yield). ^1^H NMR (500 MHz, CDCl~3~): δ 8.64 (d, *J* = 8 Hz, 1H), 7.47 (t, *J* = 7.5 Hz, 1H), 7.30--7.28 (m, 3H), 7.22 (t, *J* = 6.5 Hz, 3H), 7.17 (d, *J* = 8 Hz, 2H), 7.09 (t, *J* = 7 Hz, 2H), 6.99 (t, *J* = 7 Hz, 1H), 6.91 (t, *J* = 7.5 Hz, 1H), 6.76 (d, *J* = 7.5 Hz, 1H), 6.54 (s, 1H), 3.63 (s, 3H), 3.14 (s, 3H), 2.42--2.38 (m, 1H), 0.95--0.85 (m, 4H), ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 146.7, 142.6, 140.5, 139.3, 136.5, 135.8, 131.0, 130.3, 129.6, 129.3, 129.2, 127.2, 126.7, 126.3, 125.6, 124.8, 121.8, 121.6, 120.2, 119.6, 118.9, 116.0, 112.7, 109.0, 108.6, 99.3, 32.8, 31.1, 20.8, 13.8 ppm. Anal. Calcd for C~31~H~25~IN~2~: C, 67.40; H, 4.56; N, 5.07. Found: C, 67.32; H, 4.51; N, 5.12. EI-LRMS *m*/*z*: calcd for C~31~H~23~IN~2~ \[M -- 2\], 550; found, 550. HRMS (ESI-TOF) *m*/*z*: calcd for C~31~H~26~IN~2~ \[M + 1\]^+^, 553.1140; found, 553.1142.

### Synthesis of 4-Hexyl-3-iodo-9-methyl-1-(1-methyl-1*H*-indol-3-yl)-2-phenyl-9*H*-carbazole (**2n**) {#sec4.2.14}

The reaction of 1,1-bis(1-methyl-1*H*-indol-3-yl)-2-phenyldec-3-yn-2-ol (**1n**) (162 mg, 0.33 mmol) and molecular iodine (100 mg, 0.39 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (104 mg, 53% yield, mp = 164--165 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 8.17 (d, *J* = 7 Hz, 1H), 7.47 (t, *J* = 8 Hz, 1H), 7.29 (t, *J* = 8 Hz, 3H), 7.23--7.16 (m, 4H), 7.07 (d, *J* = 7.5 Hz, 1H), 6.98 (t, *J* = 7.5 Hz, 1H), 6.91 (t, *J* = 6.5 Hz, 1H), 6.76 (d, *J* = 8 Hz, 1H), 6.55 (s, 1H), 3.62 (s, 3H), 3.15 (s, 3H), 1.88 (t, *J* = 8 Hz, 2H), 1.72--1.67 (m, 2H), 1.50--1.41 (m, 6H), 0.95 (t, *J* = 7 Hz, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 147.1, 146.4, 142.6, 140.6, 140.2, 135.9, 130.9, 130.4, 129.4, 129.1, 127.3, 126.7, 126.3, 125.6, 122.7, 122.2, 121.6, 121.4, 120.3, 119.6, 119.5, 115.7, 112.9, 109.0, 97.7, 40.4, 32.7, 31.8, 31.2, 30.0, 28.3, 22.8, 14.2 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~34~H~34~IN~2~ \[M + H\]^+^, 597.1766; found, 597.1766.

### Synthesis of 6-Bromo-1-(5-bromo-1*H*-indol-3-yl)-3-iodo-2,4-diphenyl-9*H*-carbazole (**2o**) {#sec4.2.15}

The reaction of 1,1-bis(5-bromo-1*H*-indol-3-yl)-2,4-diphenylbut-3-yn-2-ol (**1o**) (155 mg, 0.25 mmol) and molecular iodine (77 mg, 0.3 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a sticky brown solid (133 mg, 73% yield). ^1^H NMR (500 MHz, CDCl~3~): δ 8.17 (s, 1H), 7.94 (s, 1H), 7.62 (t, *J* = 7.5 Hz, 3H), 7.48 (s, 1H), 7.45 (d, *J* = 9.5 Hz, 1H), 7.39 (d, *J* = 9.5 Hz, 2H), 7.37 (t, *J* = 6.5 Hz, 2H), 7.33 (d, *J* = 9.5 Hz, 1H), 7.24 (s, 1H), 7.18 (t, *J* = 7.5 Hz, 1H), 7.16--7.08 (m, 2H), 6.94 (d, *J* = 7.5 Hz, 1H), 6.79 (d, *J* = 6.5 Hz, 1H), 6.65 (s, 1H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 145.4, 144.4, 144.3, 141.3, 139.4, 138.3, 134.2, 131.2, 129.5, 129.4, 129.2, 129.1, 128.9, 128.4, 127.9, 127.2, 127.1, 126.1, 125.6, 125.2, 124.8, 122.2, 121.1, 116.2, 113.8, 113.1, 112.5, 112.1, 111.8, 96.6 ppm. Anal. Calcd for C~32~H~19~Br~2~IN~2~: C, 53.51; H, 2.67; N, 3.90. Found: C, 53.62; H, 2.61; N, 3.96. EI-LRMS *m*/*z*: calcd for C~32~H~17~Br~2~IN~2~ \[M -- 2\], 713; found, 713.

### Synthesis of 3-Iodo-6-methoxy-1-(5-methoxy-1*H*-indol-3-yl)-2,4-diphenyl-9*H*-carbazole (**2p**) {#sec4.2.16}

The reaction of 1,1-bis(5-methoxy-1*H*-indol-3-yl)-2,4-diphenylbut-3-yn-2-ol (**1p**) (90 mg, 0.17 mmol) and molecular iodine (53 mg, 0.21 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (60 mg, 56% yield, mp = 129--130 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 7.99 (s, 1H), 7.84 (s, 1H), 7.56 (t, *J* = 7.2 Hz, 2H), 7.50--7.41 (m, 2H), 7.27 (t, *J* = 7.6 Hz, 1H), 7.21 (s, 2H), 7.13 (t, *J* = 7.2 Hz, 2H), 7.07 (d, *J* = 8.8 Hz, 1H), 7.02 (t, *J* = 7.6 Hz, 1H), 6.92 (d, *J* = 7.6 Hz, 1H), 6.86--6.81 (m, 2H), 6.73 (d, *J* = 4.2 Hz, 1H), 6.66 (d, *J* = 4.2 Hz, 1H), 5.97 (s, 1H), 3.64 (s, 3H), 3.42 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 154.6, 153.4, 145.8, 144.8, 143.7, 140.6, 139.7, 134.6, 131.6, 130.7, 129.9, 129.6, 128.9, 128.8, 128.0, 127.9, 127.0, 126.9, 125.7, 123.4, 121.8, 117.1, 115.6, 112.9, 112.3, 112.2, 111.2, 104.7, 101.2, 95.4, 56.0, 55.4 ppm. Anal. Calcd for C~34~H~25~IN~2~O~2~: C, 65.81; H, 4.06; N, 4.51. Found: C, 65.72; H, 4.12; N, 4.43. EI-LRMS *m*/*z*: calcd for C~34~H~24~IN~2~O~2~ \[M -- 1\], 619; found, 619.

### Synthesis of 3-Iodo-6-methoxy-1-(5-methoxy-1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)-9*H*-carbazole (**2q**) {#sec4.2.17}

The reaction of 1,1-bis(5-methoxy-1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)but-3-yn-2-ol (**1q**) (100 mg, 0.19 mmol) and molecular iodine (58 mg, 0.22 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a gummy brown solid (73 mg, 62% yield). ^1^H NMR (400 MHz, CDCl~3~): δ 8.03 (s, 1H), 7.88 (s, 1H), 7.43 (t, *J* = 6.4 Hz, 3H), 7.36 (t, *J* = 6.8 Hz, 1H), 7.19 (t, *J* = 7.2 Hz, 1H), 7.14--7.11 (m, 2H), 6.98 (d, *J* = 7.6 Hz, 1H), 6.93--6.88 (m, 3H), 6.79 (s, 1H), 6.66 (s, 1H), 6.65 (d, *J* = 6.4 Hz, 1H), 6.51 (d, *J* = 5.4 Hz, 1H), 6.08 (s, 1H), 3.71 (s, 3H), 3.52 (s, 3H), 2.51 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 154.6, 153.4, 145.9, 143.1, 142.0, 140.7, 139.7, 137.7, 134.6, 131.6, 130.7, 129.7, 129.7, 129.6, 127.8, 127.2, 127.1, 126.9, 125.7, 123.5, 122.0, 117.0, 115.5, 112.9, 112.3, 112.2, 111.1, 104.9, 101.2, 95.8, 55.9, 55.3, 21.6 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~35~H~28~IN~2~O~2~ \[M + H\]^+^, 635.1195; found, 635.1197.

### Synthesis of 2-(4-Chlorophenyl)-1-(1*H*-indol-3-yl)-3-iodo-4-phenyl-9*H*-carbazole (**2r**) {#sec4.2.18}

The reaction of 2-(4-chlorophenyl)-1,1-di(1*H*-indol-3-yl)-4-phenylbut-3-yn-2-ol (**1r**) (170 mg, 0.35 mmol) and molecular iodine (107 mg, 0.42 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (147 mg, 71% yield, mp = 172--173 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 8.17 (s, 1H), 7.98 (s, 1H), 7.62--7.57 (m, 3H), 7.49--7.37 (m, 5H), 7.33--7.24 (m, 3H), 7.19 (d, *J* = 8 Hz, 1H), 7.12 (t, *J* = 7.5 Hz, 1H), 7.01 (d, *J* = 8 Hz, 1H), 6.90 (t, *J* = 8 Hz, 1H), 6.85 (d, *J* = 8 Hz, 1H), 6.72 (s, 1H), 6.61 (d, *J* = 8 Hz, 1H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 144.9, 144.2, 142.2, 140.9, 139.7, 139.2, 135.7, 132.9, 132.8, 131.0, 129.7, 129.4, 129.0, 128.1, 127.4, 126.6, 126.2, 125.0, 123.0, 122.6, 122.5, 122.0, 120.5, 119.9, 119.6, 117.0, 112.1, 111.7, 110.6, 95.8 ppm. Anal. Calcd for C~32~H~20~ClIN~2~: C, 64.61; H, 3.39; N, 4.71. Found: C, 64.48; H, 3.34; N, 4.78. EI-LRMS *m*/*z*: calcd for C~32~H~20~ClIN~2~ \[M\], 594; found, 594. HRMS (ESI-TOF) *m*/*z*: calcd for C~32~H~20~ClIN~2~Na \[M + Na\]^+^, 617.0257; found, 617.0255.

### Synthesis of 2-(4-Chlorophenyl)-3-iodo-6-methoxy-1-(5-methoxy-1*H*-indol-3-yl)-4-phenyl-9*H*-carbazole (**2s**) {#sec4.2.19}

The reaction of 2-(4-chlorophenyl)-1,1-bis(5-methoxy-1*H*-indol-3-yl)-4-phenylbut-3-yn-2-ol (**1s**) (100 mg, 0.18 mmol) and molecular iodine (56 mg, 0.22 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (92 mg, 77% yield, mp = 211--212 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 8.07 (s, 1H), 7.88 (s, 1H), 7.62 (t, *J* = 7.5 Hz, 2H), 7.57--7.46 (m, 3H), 7.38 (t, *J* = 8 Hz, 1H), 7.32 (d, *J* = 8.5 Hz, 2H), 7.14 (d, *J* = 7.5 Hz, 1H), 7.05 (d, *J* = 8 Hz, 1H), 6.93--6.90 (m, 3H), 6.78 (d, *J* = 7 Hz, 1H), 6.72 (s, 1H), 6.05 (d, *J* = 7.5 Hz, 1H), 3.71 (s, 3H), 3.49 (s, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 154.8, 153.6, 144.7, 144.2, 141.9, 140.8, 139.7, 134.6, 133.0, 132.8, 131.1, 130.8, 129.9, 129.6, 129.0, 128.9, 128.2, 128.1, 127.5, 127.1, 125.6, 123.4, 122.1, 117.2, 115.9, 113.1, 112.4, 112.1, 111.3, 104.8, 101.2, 94.9, 56.0, 55.4 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~34~H~24~ClIN~2~NaO~2~ \[M + Na\]^+^, 677.0469; found, 677.0468.

### Synthesis of 9-Benzyl-1-(1-benzyl-5-methoxy-1*H*-indol-3-yl)-3-iodo-6-methoxy-2,4-diphenyl-9*H*-carbazole (**2t**) {#sec4.2.20}

The reaction of 1,1-bis(1-benzyl-5-methoxy-1*H*-indol-3-yl)-2,4-diphenylbut-3-yn-2-ol (**1t**) (176 mg, 0.25 mmol) and molecular iodine (77 mg, 0.3 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (146 mg, 72% yield, mp = 225--226 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 7.65 (t, *J* = 7.2 Hz, 2H), 7.59--7.54 (m, 3H), 7.16--7.05 (m, 10H), 6.97 (s, 2H), 6.93--6.89 (m, 2H), 6.73--6.66 (m, 2H), 6.46 (t, *J* = 6.4 Hz, 4H), 6.14 (s, 1H), 5.02 (d, *J* = 12.4 Hz, 2H), 4.90 (d, *J* = 17.6 Hz, 1H), 4.63 (d, *J* = 14.4 Hz, 2H), 3.72 (s, 3H), 3.48 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 154.5, 153.6, 146.4, 146.2, 145.0, 141.1, 140.1, 138.7, 137.4, 137.2, 130.7, 130.5, 129.8, 129.5, 129.3, 129.0, 128.6, 128.1, 128.0, 127.3, 127.2, 126.9, 126.5, 126.4, 126.1, 125.1, 122.5, 117.2, 115.8, 112.3, 111.5, 110.4, 109.8, 104.8, 101.3, 95.3, 55.9, 55.4, 49.7, 47.2 ppm. Anal. Calcd for C~48~H~37~IN~2~O~2~: C, 72.00; H, 4.66; N, 3.50. Found: C, 72.16; H, 4.71; N, 3.45. EI-LRMS *m*/*z*: calcd for C~48~H~39~IN~2~O~2~ \[M + 2\], 802; found, 802. HRMS (ESI-TOF) *m*/*z*: calcd for C~48~H~38~IN~2~O~2~ \[M + H\]^+^, 801.1977; found, 801.1978.

### Synthesis of 3-Iodo-2,4-diphenyl-1-(2,4,6-trimethoxyphenyl)-9*H*-carbazole (**4a**) {#sec4.2.21}

The reaction of 1-(1*H*-indol-3-yl)-2,4-diphenyl-1-(2,4,6-trimethoxyphenyl)but-3-yn-2-ol (**3a**) (100 mg, 0.19 mmol) and molecular iodine (60 mg, 0.23 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a brown solid (86 mg, 71% yield, mp = 125--126 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 7.92 (s, 1H), 7.61--7.54 (m, 3H), 7.50--7.48 (m, 2H), 7.26--7.25 (m, 2H), 7.18--7.15 (m, 5H), 6.88--6.84 (m, 1H), 6.59 (d, *J* = 8 Hz, 1H), 6.03 (s, 2H), 3.79 (s, 3H), 3.60 (s, 6H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 161.6, 158.7, 145.7, 145.2, 143.9, 140.6, 139.8, 139.5, 129.8, 129.7, 128.8, 127.9, 126.8, 126.7, 125.7, 123.6, 122.4, 121.7, 119.3, 116.8, 110.4, 107.0, 95.8, 90.4, 55.6, 55.4 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~33~H~27~INO~3~ \[M + H\]^+^, 612.1035; found, 612.1036.

### Synthesis of 3-Iodo-2-phenyl-4-(*p*-tolyl)-1-(2,4,6-trimethoxyphenyl)-9*H*-carbazole (**4b**) {#sec4.2.22}

The reaction of 1-(1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)-1-(2,4,6-trimethoxyphenyl)but-3-yn-2-ol (**3b**) (100 mg, 0.19 mmol) and molecular iodine (58 mg, 0.23 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a pale white solid (81 mg, 68% yield, mp = 144--145 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 7.76 (s, 1H), 7.38--7.37 (m, 3H), 7.26 (d, *J* = 4 Hz, 2H), 7.18--7.16 (m, 7H), 6.90--6.86 (m, 1H), 6.66 (d, *J* = 8 Hz, 1H), 6.03 (s, 2H), 3.78 (s, 3H), 3.60 (s, 6H), 2.52 (s, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 161.7, 158.8, 145.8, 144.0, 142.3, 140.7, 139.9, 139.6, 137.5, 131.8, 129.9, 129.6, 129.5, 128.3, 126.8, 126.7, 125.6, 123.7, 122.5, 121.8, 119.2, 116.7, 110.4, 107.2, 96.2, 90.5, 55.6, 55.4, 21.7 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~34~H~29~INO~3~ \[M + H\]^+^, 626.1192; found, 626.1193.

### Synthesis of 9-Benzyl-3-iodo-2-phenyl-4-(*p*-tolyl)-1-(2,4,6-trimethoxyphenyl)-9*H*-carbazole (**4c**) {#sec4.2.23}

The reaction of 1-(1-benzyl-1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)-1-(2,4,6-trimethoxyphenyl)but-3-yn-2-ol (**3c**) (100 mg, 0.16 mmol) and molecular iodine (50 mg, 0.19 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a pale yellow solid (90 mg, 82% yield, mp = 261--262 °C). ^1^H NMR (500 MHz, CDCl~3~): δ 7.40 (s, 4H), 7.24 (d, *J* = 8.5 Hz, 2H), 7.12--7.08 (m, 8H), 6.89 (t, *J* = 7.5 Hz, 1H), 6.68 (s, 2H), 6.63 (d, *J* = 7 Hz, 1H), 5.66 (s, 2H), 5.14 (s, 2H), 3.68 (s, 3H), 3.32 (s, 6H), 2.53 (s, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 161.4, 158.4, 146.3, 145.0, 142.4, 142.3, 140.6, 139.1, 138.1, 137.5, 129.6(2), 129.1, 128.0, 126.6, 126.3, 125.8, 125.7, 122.8, 122.7, 122.5, 119.2, 116.8, 109.1, 108.3, 96.8, 89.6, 55.3, 54.9, 47.2, 21.7 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~41~H~34~INNaO~3~ \[M + Na\]^+^, 738.1487; found, 737.1478.

### Synthesis of 3-Iodo-9-methyl-2-phenyl-4-(*p*-tolyl)-1-(2,4,6-trimethoxyphenyl)-9*H*-carbazole (**4d**) {#sec4.2.24}

The reaction of 1-(1-methyl-1*H*-indol-3-yl)-2-phenyl-4-(*p*-tolyl)-1-(2,4,6-trimethoxyphenyl)but-3-yn-2-ol (**3d**) (80 mg, 0.15 mmol) and molecular iodine (45 mg, 0.18 mmol) in EtOAc (3 mL), following general procedure, yielded a pure product as a pale yellow solid (80 mg, 84% yield, mp = 240--241 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 7.39 (d, *J* = 8 Hz, 2H), 7.34--7.30 (m, 3H), 7.23 (t, *J* = 7.6 Hz, 1H), 7.16--7.12 (m, 5H), 6.87 (t, *J* = 7.6 Hz, 1H), 6.59 (d, *J* = 8 Hz, 1H), 5.94 (s, 2H), 3.75 (s, 3H), 3.60 (s, 6H), 3.33 (s, 3H), 2.51 (s, 3H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 161.5, 158.8, 146.3, 144.6, 142.4, 142.1, 140.6, 139.5, 137.4, 129.6, 129.5, 129.4, 126.7, 126.6, 125.5, 122.5, 122.4, 118.7, 116.5, 109.2, 108.3, 96.2, 89.7, 55.4, 55.3, 30.4, 21.7 ppm. HRMS (ESI-TOF) *m*/*z*: calcd for C~35~H~31~INO~3~ \[M + H\]^+^, 640.1348; found, 640.1348.

### Synthesis of 1-(1*H*-Indol-3-yl)-2,3,4-triphenyl-9*H*-carbazole (**5**) {#sec4.2.25}

PhB(OH)~2~ (32 mg, 0.26 mmol) was added to a solution of 1-(1*H*-indol-3-yl)-3-iodo-2,4-diphenyl-9*H*-carbazole (**2a**) (100 mg, 0.17 mmol) in dimethylformamide (DMF)/H~2~O (2:1; 3.0 mL) that contained Na~2~CO~3~ (19 mg, 1 equiv), and the resulting mixture was stirred at room temperature for 5 min. Pd(OAc)~2~ (5 mol %) was then added, and the flask was flushed with N~2~ and sealed. The mixture was stirred at 100 °C for 4 h and then filtered. The filter cake was washed with diethyl ether, and the combined filtrates were extracted with diethyl ether. The combined organic layers were washed with water and brine and then dried with anhydrous Na~2~SO~4~. After filtration, the solvent was evaporated under reduced pressure, and the crude residue was purified by column chromatography on silica gel to isolate the pure product as a brown solid (72 mg, 80% yield, mp = 236--237 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 7.96 (s, 1H), 7.90 (s, 1H), 7.43 (d, *J* = 8.4 Hz, 2H), 7.27 (d, *J* = 8 Hz, 2H), 7.20--7.7.11 (m, 6H), 7.06 (t, *J* = 8.8 Hz, 3H), 6.92 (t, *J* = 8 Hz, 2H), 6.82--6.69 (m, 8H), 6.58 (s, 1H) ppm. ^13^C NMR (100 MHz, CDCl~3~): δ 141.4, 140.7, 140.4, 140.0, 139.6, 138.5, 135.8, 135.2, 133.3, 132.3, 132.1, 131.8, 130.9, 130.6, 130.3, 129.9, 129.4, 128.5, 128.2, 127.8, 127.1, 126.7 (2C), 126.4, 125.5, 125.4, 125.1 (2C), 123.7, 122.5, 122.3, 120.6, 120.2, 119.1, 119.6, 112.6, 111.5, 110.5 ppm. Anal. Calcd for C~38~H~26~N~2~: C, 89.38; H, 5.13; N, 5.49. Found: C, 89.23; H, 5.17; N, 5.42. EI-LRMS *m*/*z*: calcd for C~38~H~25~N~2~ \[M -- 1\], 509; found, 509.

### Synthesis of Ethyl (*E*)-3-(9-Methyl-1-(1-methyl-1*H*-indol-3-yl)-2,4-diphenyl-9*H*-carbazol-3-yl)acrylate (**6**) {#sec4.2.26}

Ethyl acrylate (34 mg, 0.33 mmol) was added to a solution of 3-iodo-9-methyl-1-(1-methyl-1*H*-indol-3-yl)-2,4-diphenyl-9*H*-carbazole (**2j**) (100 mg, 0.17 mmol), in DMF (2 mL) that contained K~2~CO~3~ (58 mg, 0.42 mmol) and Bu~4~NBr (54 mg, 0.16 mmol) and the resulting mixture was stirred at room temperature for 5 min. 5 mol % Pd(OAc)~2~ was added, and the flask was flushed with N~2~ and sealed. The mixture was stirred at 80 °C for 22 h, then filtered and washed with diethyl ether. Water was added to the organic layer, which was then extracted with diethyl ether. The combined organic layers were washed with water and brine and then dried over anhydrous Na~2~SO~4~. Solvent was removed under reduced pressure, and the crude residue was purified by column chromatography on silica gel to give **12** as a brown solid (77 mg, 81% yield, mp = 228--229 °C). ^1^H NMR (400 MHz, CDCl~3~): δ 7.57 (q, *J* = 5.6 Hz, 3H), 7.49 (t, *J* = 6.8 Hz, 2H), 7.36--7.28 (m, 3H), 7.24--7.20 (m, 4H), 7.05 (d, *J* = 6.8 Hz, 2H), 6.92 (t, *J* = 7.2 Hz, 3H), 6.83 (d, *J* = 6 Hz, 1H), 6.63 (t, *J* = 8 Hz, 2H), 5.03 (d, *J* = 16 Hz, 1H), 3.93 (q, *J* = 6.8 Hz, 2H), 3.66 (s, 3H), 3.20 (s, 3H), 1.06 (t, *J* = 7.2 Hz, 3H) ppm. ^13^C NMR (125 MHz, CDCl~3~): δ 167.2, 144.2, 143.1, 140.0, 137.1, 130.9, 130.8, 129.7, 129.6, 129.4, 129.3, 129.1, 128.9, 128.8, 127.8, 127.3, 127.2, 126.9, 126.6, 126.2, 125.6, 123.7, 122.8, 122.4, 121.7, 121.6, 120.8, 120.2, 119.5, 119.2, 119.0, 116.8, 111.7, 108.9, 108.6, 59.6, 32.6, 30.9, 14.0 ppm. Anal. Calcd for C~39~H~32~N~2~O~2~: C, 83.54; H, 5.75; N, 5.00. Found: C, 83.45; H, 5.71; N, 5.08. EI-LRMS *m*/*z*: calcd for C~39~H~33~N~2~O~2~ \[M + 1\], 561; found, 561.
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